Skip to content

Accurate diagnosis and treatment evaluation system and application of gastric cancer based on CTC liquid biopsy intelligent screening

Accurate diagnosis and treatment evaluation system and application of gastric cancer based on CTC liquid biopsy intelligent screening

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037718
Enrollment
Unknown
Registered
2020-08-30
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

case series:Nil

Sponsors

Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: a. Patients with gastric cancer confirmed by imaging diagnosis after multidisciplinary discussion; b. Age >= 18 years old; c. There are measurable or evaluable tumor lesions by CT or MRI (according to RECIST 1.1 standard); d. KPS score is greater than 60; h. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: a. No pathological evidence of gastric cancer; b. Patients suffering from other malignant tumors in the past; c. Active infection period or other serious infections that may interfere with the test results of this project; d. Pregnant or breastfeeding women; e. Individuals undergoing correction monitoring or guardianship; f. Other conditions that may interfere with the test results of this project.

Design outcomes

Primary

MeasureTime frame
Circulating tumor cells;gene;

Countries

China

Contacts

Public ContactJiang Hong

Tongji Hospital

15085963135@163.com+86 13472553866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026